1. Home
  2. EVGO vs PRQR Comparison

EVGO vs PRQR Comparison

Compare EVGO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$1.37

Market Cap

195.6M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.87

Market Cap

262.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVGO
PRQR
Founded
2010
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.6M
262.5M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
EVGO
PRQR
Price
$1.37
$1.87
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$5.23
$7.25
AVG Volume (30 Days)
3.3M
865.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
N/A
EPS
N/A
N/A
Revenue
$54,588,000.00
N/A
Revenue This Year
$16.45
N/A
Revenue Next Year
$29.44
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
145.74
N/A
52 Week Low
$1.23
$1.33
52 Week High
$5.18
$3.10

Technical Indicators

Market Signals
Indicator
EVGO
PRQR
Relative Strength Index (RSI) 40.24 41.00
Support Level $1.23 $1.91
Resistance Level $1.73 $1.99
Average True Range (ATR) 0.08 0.12
MACD 0.00 -0.05
Stochastic Oscillator 31.03 0.92

Price Performance

Historical Comparison
EVGO
PRQR

About EVGO EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: